Sphene Capital Cuts AlzChem Price Target to EUR 198.40 From EUR 204.50
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
The United States Stock Market Index (100) Hit 12-week Low
US Index 100 decreased to 28353.00 Index Points, the lowest since August 2026. Over the past 4 weeks, United States Stock Market Index (100) lost 6.96%, and in the last 12 months,
L impact | EQUITY | Oct 30, 2026, 05:07 PM UTC
European markets close mixed: Euro Stoxx 50 -1.22%, DAX -0.85%, CAC 40 -0.01%, FTSE 100 +0.07%
European cash markets finished mixed: the Euro Stoxx 50 closed down 1.22 percent, the DAX closed down 0.85 percent, the CAC 40 closed down 0.01 percent and the FTSE 100 closed up 0
M impact | EQUITY | Oct 30, 2026, 05:05 PM UTC
Goldman Sachs Raises Voting Stake in AUTO1
M impact | EQUITY | Oct 30, 2026, 05:03 PM UTC
UBS Says Alnylam Fundamentals Remain Strong Despite Lower-End Guidance Expectations
UBS says Alnylam Pharmaceuticals' fundamentals remain strong despite expectations for guidance at the lower end.
M impact | EQUITY | Oct 30, 2026, 05:03 PM UTC
Morgan Stanley Raises Its Voting Stake in Norma Group
Morgan Stanley increased its voting-rights stake in Norma Group.
M impact | EQUITY | Oct 30, 2026, 05:01 PM UTC
US session market picture: S&P 500 -1.81%, Nasdaq 100 -3.51%; EUR/USD -0.2%, WTI +2.88%, INTC leads volume
US session market picture. US index futures: S and P futures is down 1.81 percent, Nasdaq futures is down 3.51 percent, Dow futures is down 0.99 percent and Russell futures is down
M impact | EQUITY | Oct 30, 2026, 05:01 PM UTC